New York, NY November 7, 2016 Mr. Sacher joins Aegis Capital to lead the firm’s Global Healthcare effort as a Managing Director. Previously, Jeff served as a Senior Banker at Goldman Sachs, Needham & Co, and Brean Capital. In addition, Mr. Sacher was the Chief Financial Officer for ViaCell, a stem cell company sold to PerkinElmer. He is a graduate of Cornell University with a degree in Biology and Northwestern’s Kellogg School of Management.
Robert Eide Aegis’ CEO Commented: “We are excited in welcoming Jeff to the Aegis family as he possesses a wealth of knowledge in the healthcare-life sciences space. Mr. Sacher will be a valued asset to the firm in his role as a Managing Director.”
David Bocchi: Head of Investment Banking Commented: “We are pleased Jeff has chosen Aegis Capital to support his clientele. We also are excited about his leadership in further expanding and enhancing our Healthcare franchise.”
About Aegis- Aegis Capital has been in business for over 30 years and maintains a conflict free service platform catering to the needs of private clients, institutions and corporations. Aegis Capital Corp. was founded in 1984 by, the current CEO and Chairman. Aegis origins were based on servicing the specific needs of its customer base. Today, we have become a premiere full-service investment banking firm with 25 locations and employees stretching from Portland, Oregon to Rochester, NY. We have clients in all 50 states and overseas. Aegis has been able to bring quality service through its clearing relationships with RBC and APEX.
For more information, contact:
Business Development
Phil Michals-800-380-4241
pmichals@aegiscapcorp.com